Goodwin, a prominent player in the field of legal practice, welcomes renowned legal practitioner Michael Siekman to their ever-expanding life sciences department. Based out of the Boston office, Siekman was officially announced as a partner on Monday.
Siekman brings a wealth of legal expertise to the table, particularly within biotechnology, biosimilars, and pharmaceutical sectors. His profound understanding of intellectual property rights, including patent prosecution, portfolio strategy, licensing, post-grant proceedings, and litigation make him an invaluable asset to Goodwin’s life sciences practice, the firm stated.
In addition, his extensive transactional practice encompasses licensing agreements, collaboration agreements, as well as dealing with intellectual property-related aspects of various corporate events such as mergers, acquisitions, initial public offerings (IPOs), and other financing deals.
For more details, check out the full story on
Bloomberg Law.